---
figid: PMC4449890__BMRI2015-827462.001
figlink: /pmc/articles/PMC4449890/figure/fig1/
number: F1
caption: 'A stepwise overview of the mechanisms of sprouty and SPRED negative regulation
  of FGF signalling. Activation of the tyrosine kinase receptor (FGFR) results in
  (1) phosphorylation of Ras and subsequent activation of the MAPK signalling cascade
  (blue arrows); (2) FGFR activation also results in the direct activation by of Sprys
  by phosphorylation and increased expression via Ras-MAPK pathway (see inset: western
  blot of increased SPRY2 following FGF1 (10 ng·mL−1) treatment of normal prostate
  epithelial cells); subsequent sequestration of the FGFR signalling molecule Grb
  (3) by pSPRY results in (4) suppression of FGF signalling. Similarly, activation
  of FGFR results in Spred heterodimerisation and subsequent complexing with Raf (5)
  resulting in inhibition of MEK activation (6).'
pmcid: PMC4449890
papertitle: 'Cosuppression of Sprouty and Sprouty-Related Negative Regulators of FGF
  Signalling in Prostate Cancer: A Working Hypothesis.'
reftext: Stephen J. Assinder, et al. Biomed Res Int. 2015;2015:827462.
pmc_ranked_result_index: '9206'
pathway_score: 0.9236744
filename: BMRI2015-827462.001.jpg
figtitle: Stepwise overview of the mechanisms of sprouty and SPRED negative regulation
  of FGF signalling
year: '2015'
organisms:
- Homo sapiens
ndex: c75b097a-decf-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4449890__BMRI2015-827462.001.html
  '@type': Dataset
  description: 'A stepwise overview of the mechanisms of sprouty and SPRED negative
    regulation of FGF signalling. Activation of the tyrosine kinase receptor (FGFR)
    results in (1) phosphorylation of Ras and subsequent activation of the MAPK signalling
    cascade (blue arrows); (2) FGFR activation also results in the direct activation
    by of Sprys by phosphorylation and increased expression via Ras-MAPK pathway (see
    inset: western blot of increased SPRY2 following FGF1 (10 ng·mL−1) treatment of
    normal prostate epithelial cells); subsequent sequestration of the FGFR signalling
    molecule Grb (3) by pSPRY results in (4) suppression of FGF signalling. Similarly,
    activation of FGFR results in Spred heterodimerisation and subsequent complexing
    with Raf (5) resulting in inhibition of MEK activation (6).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FGF9
  - FGF4
  - FGF1
  - FGF2
  - FGFR1
  - FGF10
  - SPRED2
  - SPRED3
  - FGF3
  - SPRED1
  - SPRY2
  - FGF11
  - SPRY3
  - SPRY1
  - FGF14
  - FGF20
  - MAPK1
  - MAPK3
  - RAF1
  - FGF23
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGFR3
  - FGF12
  - FGF13
  - MAP2K1
  - FGFRL1
  - MAP2K2
  - FGF21
  - FGF22
  - NRAS
  - FGF18
  - FGF17
  - FGF16
  - FGF19
  - SPRY4
  - FGFR4
  - HRAS
  - KRAS
  - FGFR2
  - Cancer
genes:
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF9
  entrez: '2254'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF4
  entrez: '2249'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF1
  entrez: '2246'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF2
  entrez: '2247'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF10
  entrez: '2255'
- word: Spred
  symbol: SPRED
  source: bioentities_symbol
  hgnc_symbol: SPRED2
  entrez: '200734'
- word: Spred
  symbol: SPRED
  source: bioentities_symbol
  hgnc_symbol: SPRED3
  entrez: '399473'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF3
  entrez: '2248'
- word: Spred
  symbol: SPRED
  source: bioentities_symbol
  hgnc_symbol: SPRED1
  entrez: '161742'
- word: Spry
  symbol: SPRY
  source: bioentities_symbol
  hgnc_symbol: SPRY2
  entrez: '10253'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF11
  entrez: '2256'
- word: Spry
  symbol: SPRY
  source: bioentities_symbol
  hgnc_symbol: SPRY3
  entrez: '10251'
- word: Spry
  symbol: SPRY
  source: bioentities_symbol
  hgnc_symbol: SPRY1
  entrez: '10252'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF14
  entrez: '2259'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF20
  entrez: '26281'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: cRaf
  symbol: c-Raf
  source: hgnc_alias_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF23
  entrez: '8074'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF5
  entrez: '2250'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF6
  entrez: '2251'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF7
  entrez: '2252'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF8
  entrez: '2253'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF12
  entrez: '2257'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF13
  entrez: '2258'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFRL1
  entrez: '53834'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF21
  entrez: '26291'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF22
  entrez: '27006'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF18
  entrez: '8817'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF17
  entrez: '8822'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF16
  entrez: '8823'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF19
  entrez: '9965'
- word: Spry
  symbol: SPRY
  source: bioentities_symbol
  hgnc_symbol: SPRY4
  entrez: '81848'
- word: SPRY2
  symbol: SPRY2
  source: hgnc_symbol
  hgnc_symbol: SPRY2
  entrez: '10253'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR4
  entrez: '2264'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: +FGF1
  symbol: FGF1
  source: hgnc_symbol
  hgnc_symbol: FGF1
  entrez: '2246'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR2
  entrez: '2263'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC4449890__F1
redirect_from: /figures/PMC4449890__F1
figtype: Figure
---
